Aclarion, Inc. Share Price

Equities

ACON

US6551872012

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 15/06/2024 am IST 5-day change 1st Jan Change
0.2999 USD +2.64% Intraday chart for Aclarion, Inc. +1.15% -90.63%
Sales 2024 * 62K 5.18M Sales 2025 * 200K 16.71M Capitalization 2.46M 205M
Net income 2024 * -6M -501M Net income 2025 * -6M -501M EV / Sales 2024 * 39.7 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 12.3 x
P/E ratio 2024 *
-0.42 x
P/E ratio 2025 *
-1.15 x
Employees 5
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.32%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.64%
1 week+1.15%
Current month-0.03%
1 month+7.88%
3 months-25.02%
6 months-91.10%
Current year-90.63%
More quotes
1 week
0.29
Extreme 0.285
0.31
1 month
0.29
Extreme 0.285
0.37
Current year
0.27
Extreme 0.2668
6.75
1 year
0.27
Extreme 0.2668
18.08
3 years
0.27
Extreme 0.2668
64.80
5 years
0.27
Extreme 0.2668
64.80
10 years
0.27
Extreme 0.2668
64.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 15/21/15
Director of Finance/CFO 61 01/21/01
Corporate Officer/Principal 52 15/21/15
Members of the board TitleAgeSince
Director/Board Member 67 01/16/01
Chairman 59 01/20/01
Director/Board Member 52 21/22/21
More insiders
Date Price Change Volume
14/24/14 0.2999 +2.64% 137,091
13/24/13 0.2922 -3.31% 111,182
12/24/12 0.3022 +0.73% 125,682
11/24/11 0.3 +2.21% 314,652
10/24/10 0.2935 -1.01% 168,737

Delayed Quote Nasdaq, June 15, 2024 at 01:30 am IST

More quotes
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.2999 USD
Average target price
1.5 USD
Spread / Average Target
+400.17%
Consensus